𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment

✍ Scribed by A. Becker; L. Crombag; D.A.M. Heideman; F.B. Thunnissen; A.W. van Wijk; P.E. Postmus; E.F. Smit


Book ID
116430834
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
127 KB
Volume
47
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.